Drostanolone Enanthate is a synthetic anabolic steroid derived from DHT, created in the late 1950s for medical use. Primarily aimed to treat muscle wasting diseases and certain cancers. With the addition of the enanthate ester, it allows for a longer duration of action, resulting in fewer injections needed. Popularity soared in bodybuilding for enhancing muscle density and strength while avoiding water retention. Categorization of the substance, as controlled prompts discussions on its misuse in sports and potential health hazards while sparking a nuanced conversation about its benefits, for therapy and performance enhancement.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about MASTERMED E 200 by Deus Medical, consult with your doctor or healthcare professional.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.